GOODWILL AND INTANGIBLE ASSETS

6 Months Ended

Sep. 30, 2023

Goodwill and Intangible Assets Disclosure [Abstract]

11. GOODWILL AND INTANGIBLE ASSETS

The changes in the carrying amount of goodwill by operating segment for fiscal 2024 are as follows:


(In thousands)	Plasma		Blood Center		Hospital		Total
Carrying amount as of April 1, 2023	$	29,043	$	33,855	$	403,333	$	466,231



Currency translation	—		(364)		(462)		(826)
Carrying amount as of September 30, 2023	$	29,043	$	33,491	$	402,871	$	465,405

The gross carrying amount of intangible assets and the related accumulated amortization as of September 30, 2023 and April 1, 2023 is as follows:


(In thousands)	Gross Carrying Amount		Accumulated Amortization		Net

As of September 30, 2023
Amortizable:
Patents	$	18,504	$	11,301	$	7,203
Capitalized software	79,431		65,028		14,403
Other developed technology	349,091		163,571		185,520
Customer contracts and related relationships	202,659		188,041		14,618
Trade names	9,508		5,151		4,357
Total	$	659,193	$	433,092	$	226,101
Non-amortizable:
In-process software development	$	7,275
In-process research and development	13,667
In-process patents	3,461
Total	$	24,403


(In thousands)	Gross Carrying Amount		Accumulated Amortization		Net

As of April 1, 2023
Amortizable:
Patents	$	18,504	$	10,831	$	7,673
Capitalized software	78,962		60,776		18,186
Other developed technology	362,506		153,099		209,407
Customer contracts and related relationships	203,240		187,774		15,466
Trade names	9,508		4,942		4,566
Total	$	672,720	$	417,422	$	255,298
Non-amortizable:
In-process software development	$	3,841
In-process research and development	13,667
In-process patents	2,965
Total	$	20,473

Refer to Note 3, Acquisitions and Strategic Investments, for additional information regarding acquisitions.

Intangible assets include the value assigned to license rights and other developed technology, patents, customer contracts and relationships and trade names. The estimated useful lives for all of these intangible assets are approximately 5 to 15 years.

In the second quarter of fiscal 2024, the Company recorded an intangible asset impairment charge of $10.4 million related to the intangibles acquired as part of the enicor GmbH acquisition completed in fiscal 2021 within the Hospital business unit.

During the three and six months ended September 30, 2023, amortization expense was $9.4 million and $19.2 million, respectively. During the three and six months ended October 1, 2022, amortization expense was $10.6 million and $21.3 million, respectively.

Future annual amortization expense on intangible assets is estimated to be as follows:


(In thousands)
Remainder of Fiscal 2024	$	18,345
Fiscal 2025	$	29,705
Fiscal 2026	$	24,023
Fiscal 2027	$	22,066
Fiscal 2028	$	20,294